InvestorsHub Logo
Followers 27
Posts 3134
Boards Moderated 0
Alias Born 01/23/2007

Re: None

Tuesday, 05/24/2011 7:56:24 AM

Tuesday, May 24, 2011 7:56:24 AM

Post# of 346073
May 26, 2011 Recombinant Antibodies Conference 2011
Barcelona, Spain

KEYNOTE PRESENTATION: Targeting tumor vasculature and REACTIVATING TUMOR IMMUNITY WITH BAVITUXIMAB: PRECLINICAL AND CLINICAL STUDIES
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News